CellWell record HH-302825
Mannosylated graphene oxide nanotherapeutics co-delivering docetaxel and a STING agonist reprogram myeloid cells and potentiate antitumor immunity
Xin Z; Dezhi L; Jingyi Z; Xuyuan C; Xin C; Shengjie Y; Yingying F; Yan L; Yinjuan L; Lu Q; Xinghe W
Materials today. Bio ยท 2026
In plain language
Mannosylated graphene oxide co-delivering docetaxel and a STING agonist suppressed primary tumor growth and significantly reduced pulmonary metastasis in mice.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-302825
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.